Literature DB >> 17038426

Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats.

Filip Bergquist1, Alasdair Ruthven, Mike Ludwig, Mayank B Dutia.   

Abstract

Vestibular compensation (the behavioural recovery that follows unilateral vestibular de-afferentation), is facilitated by histamine, and is associated with increased central histamine release and alterations in histamine H(3) receptor expression in the vestibular nuclei. However, little is known of the effects of histamine on neurotransmission in the vestibular nuclei, and the mechanisms by which histamine may influence compensation are unclear. Here we examined the modulatory effects of histaminergic agents on the release of amino acid neurotransmitters in slices of the medial vestibular nucleus (MVN) prepared from normal and labyrinthectomised rats. The release of GABA, but not glutamate, glycine or aspartate, was robustly and reproducibly evoked by a high-K(+) stimulus applied to normal MVN slices. Histamine inhibited the evoked release of GABA, both through a direct action on presynaptic H(3) receptors (presumably located on GABAergic terminals), and through a novel, indirect pathway that involved the increased release of glycine by activation of postsynaptic H(1)/H(2) receptors (presumably on glycinergic neurons). After unilateral labyrinthectomy (UL), the direct H(3) receptor-mediated inhibition of GABA release was profoundly downregulated in both ipsi-lesional and contra-lesional MVNs. This effect appeared within 25 h post-UL and persisted for at least 3 weeks post-UL. In addition, at 25 h post-UL the indirect glycinergic pathway caused a marked suppression of GABA release in the contra-lesional but not ipsi-lesional MVN, which was overcome by strychnine. Stimulation of histamine H(3) receptors at 25 h post-UL restored contra-lesional GABA release to normal, suggesting that acutely after UL H(3) receptors may strongly modulate glycinergic and GABAergic neurotransmission in the MVN. These findings are the first to demonstrate the modulatory actions of the histaminergic system on neurotransmission in the vestibular nuclei, and the changes that occur during vestibular system plasticity. During vestibular compensation, histaminergic modulation of glycine and GABA release may contribute to the rebalancing of neural activity in the vestibular nuclei of the lesioned and intact sides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038426      PMCID: PMC1890394          DOI: 10.1113/jphysiol.2006.120493

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  50 in total

1.  Effects of unilateral labyrinthectomy on GAD, GAT1 and GABA receptor gene expression in the rat vestibular nucleus.

Authors:  Arata Horii; Tadashi Kitahara; Paul F Smith; Cynthia L Darlington; Chisako Masumura; Takeshi Kubo
Journal:  Neuroreport       Date:  2003-12-19       Impact factor: 1.837

Review 2.  Distribution of histaminergic neurons and fibers in rat brain. Comparison with noradrenergic and serotonergic innervation of the vestibular system.

Authors:  H W Steinbusch
Journal:  Acta Otolaryngol Suppl       Date:  1991

Review 3.  Central histaminergic modulation of vestibular function - a review.

Authors:  F Bergquist; M B Dutia
Journal:  Sheng Li Xue Bao       Date:  2006-08-25

Review 4.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

5.  Evidence for glycine as an inhibitory neurotransmitter of vestibular, reticular, and prepositus hypoglossi neurons that project to the cat abducens nucleus.

Authors:  R F Spencer; R J Wenthold; R Baker
Journal:  J Neurosci       Date:  1989-08       Impact factor: 6.167

6.  Histamine depolarizes rat medial vestibular nucleus neurons recorded intracellularly in vitro.

Authors:  K D Phelan; J Nakamura; J P Gallagher
Journal:  Neurosci Lett       Date:  1990-02-16       Impact factor: 3.046

7.  Immunocytochemical localization of glutamic acid decarboxylase in the dorsal lateral vestibular nucleus: evidence for an intrinsic and extrinsic GABAergic innervation.

Authors:  C R Houser; R P Barber; J E Vaughn
Journal:  Neurosci Lett       Date:  1984-06-29       Impact factor: 3.046

8.  The histaminergic system in the guinea pig central nervous system: an immunocytochemical mapping study using an antiserum against histamine.

Authors:  M S Airaksinen; P Panula
Journal:  J Comp Neurol       Date:  1988-07-08       Impact factor: 3.215

9.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

10.  Neuropeptides and gamma-aminobutyric acid in the vestibular nuclei of the rat: an immunohistochemical analysis. I. Distribution.

Authors:  I Nomura; E Senba; T Kubo; T Shiraishi; T Matsunaga; M Tohyama; Y Shiotani; J Y Wu
Journal:  Brain Res       Date:  1984-10-08       Impact factor: 3.252

View more
  17 in total

1.  Depolarization-induced release of amino acids from the vestibular nuclear complex.

Authors:  Donald A Godfrey; Yizhe Sun; Christopher Frisch; Matthew A Godfrey; Allan M Rubin
Journal:  Neurochem Res       Date:  2011-12-07       Impact factor: 3.996

2.  Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Authors:  Armen A Galoyan; Naser Khalaji; Lilja E Hambardzumyan; Larisa P Manukyan; Irina B Meliksetyan; Vergine A Chavushyan; Vaghinak H Sarkisian; John S Sarkissian
Journal:  Neurochem Res       Date:  2010-08-12       Impact factor: 3.996

3.  Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.

Authors:  Anne C Baakman; Rob Zuiker; Joop M A van Gerven; Nicholas Gross; Ronghua Yang; Michael Fetell; Ari Gershon; Yossi Gilgun-Sherki; Edward Hellriegel; Ofer Spiegelstein
Journal:  Br J Clin Pharmacol       Date:  2019-03-14       Impact factor: 4.335

4.  Histamine H1 Receptor Contributes to Vestibular Compensation.

Authors:  Zhang-Peng Chen; Xiao-Yang Zhang; Shi-Yu Peng; Zhong-Qin Yang; Yan-Bo Wang; Yang-Xun Zhang; Xi Chen; Jian-Jun Wang; Jing-Ning Zhu
Journal:  J Neurosci       Date:  2018-11-09       Impact factor: 6.167

5.  Superficial Layer-Specific Histaminergic Modulation of Medial Entorhinal Cortex Required for Spatial Learning.

Authors:  Chao He; Fenlan Luo; Xingshu Chen; Fang Chen; Chao Li; Shuancheng Ren; Qicheng Qiao; Jun Zhang; Luis de Lecea; Dong Gao; Zhian Hu
Journal:  Cereb Cortex       Date:  2015-01-16       Impact factor: 5.357

6.  Calyx and dimorphic neurons of mouse Scarpa's ganglion express histamine H3 receptors.

Authors:  Simona Tritto; Laura Botta; Valeria Zampini; Gianpiero Zucca; Paolo Valli; Sergio Masetto
Journal:  BMC Neurosci       Date:  2009-06-29       Impact factor: 3.288

7.  Postsynaptic mechanisms underlying the excitatory action of histamine on medial vestibular nucleus neurons in rats.

Authors:  Xiao-Yang Zhang; Lei Yu; Qian-Xing Zhuang; Shi-Yu Peng; Jing-Ning Zhu; Jian-Jun Wang
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

8.  Role of the commissural inhibitory system in vestibular compensation in the rat.

Authors:  Filip Bergquist; Mike Ludwig; Mayank B Dutia
Journal:  J Physiol       Date:  2008-07-17       Impact factor: 5.182

9.  The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex.

Authors:  Natalie Welty; James R Shoblock
Journal:  Psychopharmacology (Berl)       Date:  2009-10-01       Impact factor: 4.530

10.  Functional role of cyclic nucleotide-gated channels in rat medial vestibular nucleus neurons.

Authors:  Maria Vittoria Podda; Marcello D'Ascenzo; Lucia Leone; Roberto Piacentini; Gian Battista Azzena; Claudio Grassi
Journal:  J Physiol       Date:  2007-11-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.